Meet Pharmidex Oncology team at Supa 2017
April 23, 2017
Pharmidex Oncology team will be attending the SUPA 2017 conference in Birmingham
Meet Pharmidex Oncology team at Supa 2017 in Birmingham
Meet the Pharmidex team at Supa 2017 in Birmingham from the 23-25 April 2017. Head of Oncology at Pharmidex Chris Ireson will be building on existing collaborations whilst exploring new opportunities as well.
Pharmidex is delighted to share that Ash Alavijeh , Head of Operations, will be attending the UK BioIndustry Association (BIA) Annual Gala Dinner at the Roundhouse, London. Ash is looking forward to connecting with pharma and biotech colleagues to explore new collaborations, partnerships, and opportunities, all with the shared goal of advancing drug discovery and development. If you’re attending, feel free to connect with Ash this evening.
Pharmidex provides comprehensive biomarker and cytokine profiling services to support drug discovery and development across respiratory, autoimmune, metabolic and toxicology programmes. Using state-of-the-art bioanalytical platforms, we deliver robust, translational biomarker data to help understand mechanism of action, immune modulation and therapeutic efficacy. Let’s talk about how our biomarker expertise can strengthen your research. 🌐 https://www.pharmidex.com/BIOMARKERS_ANALYSIS
We’re delighted to share that Vasudha Tandon, PhD Principal Scientist at Pharmidex , will be attending the BBMS Gala Dinner 2026 on Thursday 22 January 2026 at the Old Hall, Queens’ College, Cambridge. This special evening, part of Building Bridges in Medical Sciences, brings together leaders from academia, industry, and healthcare to strengthen collaboration across the life sciences. Vasudha is looking forward to meeting fellow attendees and exploring new opportunities to build meaningful scientific partnerships.
